newsimpactscreener logonewsimpactscreener
Insights
Correction Stress TestArticlesTopicsQuotesThe ArenaFamous TradersCEOsResearch
Free services
Daily News BriefingMarket Screenings
PricingDocsBlogSign inSign up
newsimpactscreener logonewsimpactscreener
Insights
Correction Stress TestArticlesTopicsQuotesThe ArenaFamous TradersCEOsResearch
Free services
Daily News BriefingMarket Screenings
PricingDocsBlogSign inSign up
newsimpactscreener— news connected to markets.
@newsimpactscrnr on X@newsimpactscreener on InstagramAboutBriefingsTermsPrivacy

Correction stress test

Whose priced-in story survives the correction?

Every share price is a bet on growth. For each stock we take the growth its price now requires — a ten-year reverse DCF at the latest close — and set it against what analysts forecast for the next three years. Then we ask how far those forecasts can be cut before the price is paying for growth nobody expects. A correction is exactly when forecasts get cut.

Get the next analysis by email

The stress test is re-run as forecasts move. Leave your email and we'll send you each new one.

One email per new analysis. Unsubscribe in one click.

How to read it — and what it is not

  • Comes out on top. Survives a bust-sized cut to analyst growth (10 points, or half the forecast if larger), with the median analyst target at least 15% above the price and no more than one earnings-quality red flag.
  • Holds. Survives a correction-sized 3-point cut to analyst growth.
  • Fragile. Paid for today, but breaks on a small cut — or only looks over-priced at a 9% discount rate.
  • Drowns. The price already needs more growth than analysts forecast, at both a 9% and an 8% discount rate.
  • Exposure is a separate axis: a stock that is part of the AI epicenter, or linked to it as a supplier, customer or partner and volatile, will fall with it while the correction runs, even if its story holds.
  • Earnings quality checks whether the profit behind the analysts' margin arrives as cash, from the last three filed annual statements. Where it does not, the test also runs at the margin cut by that shortfall and keeps the smaller cushion. Two or more red flags (cash conversion, accruals, stock-based pay, dilution, one-off gains, negative free cash flow) rule a name out of “comes out on top”. Heavy capex is shown but not penalised: investment is not bad earnings.
  • This is not a forecast that a stock will rise. Our own test of the price-implied growth on its own found it does not predict returns. The groups describe whether a narrative is still paid for by analyst forecasts. Each day's list is sealed with a hash so it can be graded against what happens next; it has not been graded yet.
  • The cut sizes are stated assumptions, not values fitted to history. Analyst targets set before the drop make “distance to median target” look larger than analysts would say today.
  • The reconstructions themselves are on each company's quote page. Not investment advice.

Prices as of Nov 20, 2026 · analyst consensus snapshot Nov 21, 2026 · 627 names with a priced-in reconstruction

Comes out on top
14
Holds
104
Fragile
98
Drowns
222
Not valued on cash flow
188

Survives a bust-sized cut to analyst growth (10 points, or half the forecast if larger), with the median analyst target at least 15% above the price and no more than one earnings-quality red flag.

JDJD.com, Inc. · Consumer Cyclicallow exposure
Absorbs a cut of +27ptPrice needs −11.4%/yrAnalysts +6.8%/yrFrom peak −15.3%

At a 2.5% margin the price needs -11.4% a year of revenue growth against a 6.8% 3-year consensus: cushion +26.9pt, clearing the 1pt correction cut by 25.9pt. Price pays ~13% growth and continued retail margin gains, rejecting a 20% path.

Breaks if: 3y consensus is cut by more than 26.9pt (vs 1pt assumed) or margin settles below 2.5%. Watch: Q4 earnings, est. early Mar 2027.

Full breakdown →
NBIXNeurocrine Biosciences, Inc. · Healthcarelow exposure
Absorbs a cut of +22ptPrice needs +0.6%/yrAnalysts +21.0%/yrFrom peak −13.7%

At a 26.0% margin the price requires 0.6% 3y revenue CAGR against 21.0% consensus, a cushion of +21.8pt versus a 0pt correction cut. Cushion is wide and the drawdown is not the company's own; it should come out ahead of the correction. Launch story intact; unaffected.

Breaks if: the launch ramp misses the 21% consensus CAGR

Full breakdown →
REGNRegeneron Pharmaceuticals, Inc. · Healthcarelow exposure
Absorbs a cut of +18ptPrice needs −1.0%/yrAnalysts +14.8%/yrat a cash-adjusted 31% marginFrom peak −5.4%

At a 31.0% margin the price requires -1.0% 3y revenue CAGR against 14.8% consensus, a cushion of +18.1pt versus a 0pt correction cut. Cushion is wide and the drawdown is not the company's own; it should come out ahead of the correction. Unaffected.

Breaks if: Eylea erosion outruns the new launches

Full breakdown →
VALEVale S.A. · Basic Materialslow exposure
Absorbs a cut of +18ptPrice needs −7.9%/yrAnalysts +3.0%/yrFrom peak −39.7%

Deep-value miner. At a 16.0% margin the price needs -7.9%/yr against +3.0% consensus, a +17.5pt cushion against a 0.0pt cut (rule: on_top, +18.6pt at 16.8%).

Breaks if: iron ore collapses or Brazil political risk forces a re-rate

Full breakdown →
CPACopa Holdings, S.A. · Industrialslow exposure
Absorbs a cut of +17ptPrice needs −2.1%/yrAnalysts +12.2%/yrFrom peak −7.6%

At a 15.5% margin the price requires -2.1% 3y revenue CAGR against consensus 12.2%; cushion +17.4pt (+20.5pt at 1pt lower r) versus a 1pt correction cut. Fuel story, not AI. Market: none drawdown (-8% from peak), trend up.

Breaks if: Fuel spikes or Latin American travel demand falls enough to take margin below the 15.5% mid-cycle floor.

Full breakdown →
CICigna Corporation · Healthcarelow exposure
Absorbs a cut of +17ptPrice needs −6.3%/yrAnalysts +5.1%/yrFrom peak −14.2%

At a 2.8% margin the price requires -6.3% 3y revenue CAGR against 5.1% consensus, a cushion of +17.1pt versus a 0pt correction cut. Cushion is wide and the drawdown is not the company's own; it should come out ahead of the correction. Managed care, policy-driven, not AI-driven.

Breaks if: the 2026-11-20 insurer selloff reflects a real cost-trend or policy hit to Cigna's book

Full breakdown →
EOGEOG Resources, Inc. · Energylow exposure
Absorbs a cut of +15ptPrice needs −5.6%/yrAnalysts +4.6%/yrFrom peak −10.2%

On top: at a 26.0% margin the price needs -5.6% 3y revenue growth against +4.6% consensus, a +15.4pt cushion versus a 0pt correction cut. Commodity name.

Breaks if: Consensus 3y growth is cut by more than 15.4pt, or the through-cycle margin settles below 26.0%.

Full breakdown →
BBarrick Mining Corporation · Basic Materialslow exposure
Absorbs a cut of +15ptPrice needs +1.5%/yrAnalysts +16.1%/yrFrom peak −35.5%

Priced for trough gold. At a 23.5% margin the price needs +1.5%/yr against +16.1% consensus, a +15.3pt cushion against a 0.0pt cut (rule: on_top, +14.9pt at 23.1%).

Breaks if: gold slide deepens and margin falls below 23%

Full breakdown →
AUAngloGold Ashanti plc · Basic MaterialsEarnings: one red flaglow exposure
Absorbs a cut of +15ptPrice needs −0.6%/yrAnalysts +12.0%/yrFrom peak −41.3%

Priced for trough gold. At a 25.0% margin the price needs -0.6%/yr against +12.0% consensus, a +14.7pt cushion against a 0.0pt cut (rule: on_top, +13.7pt at 23.9%).

Breaks if: gold breaks well below the 14-month low and margin falls below the 23.9% floor

Full breakdown →
JAZZJazz Pharmaceuticals plc · Healthcarelow exposure
Absorbs a cut of +14ptPrice needs −2.6%/yrAnalysts +8.6%/yrFrom peak −11.5%

At a 24.0% margin the price requires -2.6% 3y revenue CAGR against 8.6% consensus, a cushion of +14.5pt versus a 0pt correction cut. Cushion is wide and the drawdown is not the company's own; it should come out ahead of the correction. Unaffected; history margin distorted by charges.

Breaks if: a product setback hits the cash margin of 29%

Full breakdown →
FLEXFlex Ltd. · Technologymedium exposure
Absorbs a cut of +14ptPrice needs +8.0%/yrAnalysts +25.4%/yrFrom peak −45.4%

At a 5.5% margin the price needs +8.0% 3y revenue CAGR against +25.4% consensus, a cushion of +13.7pt versus a 6.4pt correction cut. It clears the cut by 7.3pt with a clean margin, so it comes out on top.

Breaks if: Margin settles well below 6% or growth is cut by more than 14pt (vs the 6.4pt assumed); news trigger: Bullish, catalyst-rich (spinoff). Down 45% from peak. Spinoff is a sum-of-parts unlock hazard for shorts.

Full breakdown →
CTSHCognizant Technology Solutions Corporation · Technologylow exposure
Absorbs a cut of +12ptPrice needs −3.9%/yrAnalysts +4.3%/yrFrom peak −21.2%

At a 13.0% margin the price needs -3.9% 3y revenue CAGR against +4.3% consensus, a cushion of +12.4pt versus a 1.0pt correction cut. It clears the cut by 11.4pt with a clean margin, so it comes out on top.

Breaks if: Margin settles well below 13% or growth is cut by more than 12pt (vs the 1.0pt assumed); news trigger: Sentiment recovered (10d 0.42 vs 50d -0.07) on thin coverage. No hard news.

Full breakdown →
FANGDiamondback Energy, Inc. · EnergyEarnings: one red flaglow exposure
Absorbs a cut of +11ptPrice needs −1.9%/yrAnalysts +6.5%/yrFrom peak −17.1%

On top: at a 25.0% margin the price needs -1.9% 3y revenue growth against +6.5% consensus, a +11.3pt cushion versus a 0pt correction cut. Commodity name.

Breaks if: Consensus 3y growth is cut by more than 11.3pt, or the through-cycle margin settles below 25.0%.

Full breakdown →
EPDEnterprise Products Partners L.P. · Energylow exposure
Absorbs a cut of +11ptPrice needs +2.0%/yrAnalysts +12.3%/yrFrom peak −8.9%

On top: at a 10.0% margin the price needs +2.0% 3y revenue growth against +12.3% consensus, a +10.6pt cushion versus a 0pt correction cut. Midstream without an AI leg.

Breaks if: Consensus 3y growth is cut by more than 10.6pt, or the through-cycle margin settles below 10.0%.

Full breakdown →

Sealed Nov 21, 2026 · sha256 17914dcecc4af68c…

newsimpactscreener logonewsimpactscreener
Insights
Correction Stress TestArticlesTopicsQuotesThe ArenaFamous TradersCEOsResearch
Free services
Daily News BriefingMarket Screenings
PricingDocsBlogSign inSign up